279 related articles for article (PubMed ID: 31990955)
1. Functional and transcriptomic characterization of cisplatin-resistant AGS and MKN-28 gastric cancer cell lines.
Mora-Lagos B; Cartas-Espinel I; Riquelme I; Parker AC; Piccolo SR; Viscarra T; Reyes ME; Zanella L; Buchegger K; Ili C; Brebi P
PLoS One; 2020; 15(1):e0228331. PubMed ID: 31990955
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression.
Huang X; Li Z; Zhang Q; Wang W; Li B; Wang L; Xu Z; Zeng A; Zhang X; Zhang X; He Z; Li Q; Sun G; Wang S; Li Q; Wang L; Zhang L; Xu H; Xu Z
Mol Cancer; 2019 Mar; 18(1):71. PubMed ID: 30927924
[TBL] [Abstract][Full Text] [Related]
3. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
Zhou J; Chen Q
FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
Xi Z; Si J; Nan J
Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
[TBL] [Abstract][Full Text] [Related]
5. Next-Generation Sequencing Analysis of mRNA Profile in Cisplatin-Resistant Gastric Cancer Cell Line SGC7901.
Deng Z; Wang H; Guo G; Li X; Cai Y; Tang Y; Wang Y; Li J; Lu Z; Yu X; Li R; Li L
Med Sci Monit; 2019 Apr; 25():2386-2396. PubMed ID: 30938333
[TBL] [Abstract][Full Text] [Related]
6. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of FAM3B Promotes Cisplatin Resistance in Gastric Cancer by Inducing Epithelial-Mesenchymal Transition.
Song C; Duan C
Med Sci Monit; 2020 May; 26():e921002. PubMed ID: 32442162
[TBL] [Abstract][Full Text] [Related]
8. KLF5-mediated aquaporin 3 activated autophagy to facilitate cisplatin resistance of gastric cancer.
Dai X; Chen Y; Chen N; Dou J; Zhuang H; Wang J; Zhao X; Zhang X; Zhao H
Immunopharmacol Immunotoxicol; 2023 Apr; 45(2):140-152. PubMed ID: 36083020
[TBL] [Abstract][Full Text] [Related]
9. A systems biology approach to identify microRNAs contributing to cisplatin resistance in human ovarian cancer cells.
Liu W; Wang S; Zhou S; Yang F; Jiang W; Zhang Q; Wang L
Mol Biosyst; 2017 Oct; 13(11):2268-2276. PubMed ID: 28861582
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer effects of newly developed chemotherapeutic agent, glycoconjugated palladium (II) complex, against cisplatin-resistant gastric cancer cells.
Tanaka M; Kataoka H; Yano S; Ohi H; Kawamoto K; Shibahara T; Mizoshita T; Mori Y; Tanida S; Kamiya T; Joh T
BMC Cancer; 2013 May; 13():237. PubMed ID: 23672493
[TBL] [Abstract][Full Text] [Related]
11. Transcriptomic Landscape of Cisplatin-Resistant Neuroblastoma Cells.
Rodrigo MAM; Buchtelova H; Jimenez AMJ; Adam P; Babula P; Heger Z; Adam V
Cells; 2019 Mar; 8(3):. PubMed ID: 30871063
[TBL] [Abstract][Full Text] [Related]
12. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
[TBL] [Abstract][Full Text] [Related]
13. CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis.
Zhang Q; Miao Y; Fu Q; Hu H; Chen H; Zeng A; Jin Y; Jiang Y; Qian L; Wu L; Xu L; Wang G; Qiu L; Huang X; Xia Y
Biochem Biophys Res Commun; 2020 Jun; 526(3):713-720. PubMed ID: 32253030
[TBL] [Abstract][Full Text] [Related]
14. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
[TBL] [Abstract][Full Text] [Related]
16. All-trans retinoic acid-mediated miR-30a up-regulation suppresses autophagy and sensitizes gastric cancer cells to cisplatin.
Abbasi A; Hosseinpourfeizi M; Safaralizadeh R
Life Sci; 2022 Oct; 307():120884. PubMed ID: 35973456
[TBL] [Abstract][Full Text] [Related]
17. Role of Metastasis-Related Genes in Cisplatin Chemoresistance in Gastric Cancer.
Nishiguchi Y; Oue N; Fujiwara-Tani R; Sasaki T; Ohmori H; Kishi S; Mori S; Mori T; Ikeda N; Matsumoto S; Wakatsuki K; Luo Y; Yasui W; Sho M; Kuniyasu H
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905926
[TBL] [Abstract][Full Text] [Related]
18. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
[TBL] [Abstract][Full Text] [Related]
19. PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2.
Li H; Ma X; Yang D; Suo Z; Dai R; Liu C
J Cell Biochem; 2020 Feb; 121(2):1353-1361. PubMed ID: 31478258
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of cisplatin-resistance in MKN-45 human stomach adenocarcinoma cell line.
Hong WS; Son YS
Anticancer Res; 1996; 16(5A):3031-6. PubMed ID: 8917423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]